Diamedica Therapeutics Inc.
Ticker: DMAC
| Insider | Title |
|---|---|
| Ab Tomenterprise | 10% or greater ownership |
| Ab Trill | 10% or greater ownership |
| Amy L. Burroughs | Director |
| Charles Pauling Semba | Director |
| David J. Wambeke | Chief Business Officer |
| Dietrich John Pauls | President and CEO, Director |
| Dominic R Cundari | Chief Commercial Officer |
| Harry W Jr Alcorn | SVP, Clinical Operations |
| James T. Parsons | Director |
| Jan Stahlberg | 10% or greater ownership |
| Julie Vanorsdel Daves | SVP Clinical Development Oper. |
| Kirsten L Gruis | Chief Medical Officer |
| Koch Thomas Von | 10% or greater ownership |
| Masuoka K. Lorianne | Chief Medical Officer |
| Private Ab Tomenterprise | 10% or greater ownership |
| Randall Michael Giuffre | Director |
| Richard D. Pilnik | Director |
| Richard Kuntz | Director |
| Scott Kellen | CFO and Secretary |
| Sydney A. Gilman | VP, Regulatory Affairs |
| Tanya Lewis | Director |